dr. brufsky on challenges in breast cancer
Published 4 years ago • 209 plays • Length 1:06Download video MP4
Download video MP3
Similar videos
-
1:07
dr. brufsky on challenges facing biosimilars in breast cancer
-
1:49
dr. brufsky on multiparametric genomic assays in breast cancer
-
1:41
dr. brufsky on implementing pertuzumab in her2 breast cancer
-
1:01
dr. brufsky on trastuzumab biosimilars in breast cancer
-
1:49
dr. brufsky discusses pertuzumab in her2 breast cancer
-
0:57
dr. brufsky on biosimilars being explored in oncology
-
1:42
nci experts discuss challenges in breast cancer research
-
1:35
dr. brufsky on cdk 4/6 inihibitors in neoadjuvant breast cancer treatment
-
1:30
dr. brufsky on genomic assays for breast cancer
-
1:29
dr. brufsky on the colet trial for triple-negative breast cancer
-
1:16
dr. brufsky advises doctors on bevacizumab for breast cancer
-
1:44
adam brufsky, md, phd: choices of therapy in breast cancer
-
1:04
dr. brufsky on the disease-free survival of aromatase inhibitors for breast cancer
-
1:19
dr adam brufsky: choosing a therapy for breast cancer patients
-
1:15
dr. brufsky on reducing the cost of care in breast oncology
-
1:22
dr. brufsky on cobimetinib plus paclitaxel in tnbc
-
0:35
dr. brufsky discusses bevacizumab benefits in tnbc
-
2:20
dr. brufsky on choosing when to do a multiparameter genomic assay
-
2:10
dr. brufsky on anastrozole versus tamoxifen in dcis